Author:
Blain Alison,Greally Elizabeth,Laval Steven H.,Blamire Andrew M.,MacGowan Guy A.,Straub Volker W.
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference33 articles.
1. Spurney, C. F. (2011). Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle & Nerve, 44(1), 8–19.
2. Fayssoil, A., Nardi, O., Orlikowski, D., & Annane, D. (2010). Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics. Heart Failure Reviews, 15(1), 103–107.
3. Viollet, L., Thrush, P. T., Flanigan, K. M., Mendell, J. R., & Allen, H. D. (2012). Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. The American Journal of Cardiology, 110(1), 98–102.
4. Bushby, K., Muntoni, F., & Bourke, J. P. (2003). 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th–9th June 2002, Naarden, the Netherlands. (Vol. 13, pp. 166–172). Presented at the Neuromuscular disorders: NMD.
5. Ogata, H., Ishikawa, Y., Ishikawa, Y., & Minami, R. (2009). Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. Journal of Cardiology, 53(1), 72–78.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献